Disease Modifying Anti-rheumatic Drug and Biologic Therapy in Pregnancy: A Single-center Mixed Methods Study

被引：0
|
作者：
Glick, Lauren [1 ]
Shamis, Justin [2 ]
McGhie, Taneisha [3 ]
Mahendira, Dharini [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] North York Gen Hosp, Toronto, ON, Canada
[3] Cornwall Univ Hosp, Kingston, Saint Andrew, Jamaica
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1764
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Disease Modifying Anti-rheumatic Drugs (DMARDs) and Biologic Therapy Use During Pregnancy: A Single-center Mixed Methods Study
    Glick, Lauren
    Mahendira, Dharini
    Shamis, Justin
    McGhie, Taneisha
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 791 - 791
  • [2] Disease Modifying Anti-rheumatic Drugs ( DMARDs) and Biologic Therapy Use During Pregnancy: A Single-center Mixed Methods Study
    Glick, Lauren
    Shamis, Justin
    McGhie, Taneisha
    Mahendira, Dharini
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1125 - 1125
  • [3] COMPARATIVE EFFECTIVENESS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN US VETERANS WITH RHEUMATOID ARTHRITIS
    Cannon, G. W.
    He, T.
    Teng, C. -C.
    Leng, J.
    Lu, C. -C.
    Tang, D.
    Shah, N.
    Harrison, D. J.
    Sauer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 446 - 447
  • [4] Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
    Migkos, Michalis P.
    Kaltsonoudis, Evripidis
    Pelechas, Eleftherios
    Drossou, Vassiliki
    Karagianni, Panagiota G.
    Kavvadias, Athanasios
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (05) : 903 - 909
  • [5] Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
    Michalis P. Migkos
    Evripidis Kaltsonoudis
    Eleftherios Pelechas
    Vassiliki Drossou
    Panagiota G. Karagianni
    Athanasios Kavvadias
    Paraskevi V. Voulgari
    Alexandros A. Drosos
    Rheumatology International, 2021, 41 : 903 - 909
  • [6] Rational disease-modifying anti-rheumatic drug (DMARD) therapy: Is it possible?
    Furst, DE
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (08): : 707 - 708
  • [7] ANTI-RHEUMATIC DRUG-THERAPY DURING PREGNANCY
    BISCHOF, P
    AKTUELLE RHEUMATOLOGIE, 1978, 3 (04) : 199 - 202
  • [8] PREDICTORS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG INITIATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN KOREA
    Park, E. H.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Song, Y. W.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 302 - 302
  • [9] Disease Modifying Anti-Rheumatic Drugs Compliance Study
    Vostretsova, Kateryna
    Rogers, Pam
    Thompson, Darby J. S.
    Lacaille, Diane
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S731 - S732
  • [10] Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
    Drakopoulou, Maria
    Soulaidopoulos, Stergios
    Oikonomou, George
    Tousoulis, Dimitrios
    Toutouzas, Konstantinos
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 488 - 506
12345